Inhibition of inflammatory cytokine secretion by plant-derived compounds inuviscolide and tomentosin: The role of NFkB b and stat1

Open Pharmacology Journal

Volumn 4, Issue 1, 2010, Pages 36-44

  Abrham, Galya ^a   Dovrat, Sara ^b   Bessler, Hanna ^c   Grossman, Shlomo ^a   Nir, Uri ^a   Bergman, Margalit ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b OPEN UNIVERSITY OF ISRAEL   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

Ifn; Il 1; Il 2; Inflammation; Inula viscosa

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INUVISCOLIDE; PLANT MEDICINAL PRODUCT; STAT1 PROTEIN; STAT3 PROTEIN; TOMENTOSIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INULA VISCOSA EXTRACT; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; SYNAPTOTAGMIN I;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; TOXICITY TESTING; WESTERN BLOTTING; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIOXIDANT ACTIVITY; DRUG STRUCTURE; INULA; INULA VISCOSA; MEDICINAL PLANT; SIGNAL TRANSDUCTION;

EID: 78249257779     PISSN: None     EISSN: 18741436     Source Type: Journal    
DOI: 10.2174/1874143601004010036     Document Type: Article

References (45)

1. Máñez, S.; Recio, M.C.; Gil, I.; Gomez, C.; Giner, R.M.; Waterman, P.G.; Rios, J.L. A glycosyl analogue of diacylglycerol and other antiinflammatory constituents from Inula viscosa. J. Nat. Prod., 1999, 62, 601-604.
2. Hernandez, V.; del Carmen Recio, M.; Manez, S.; Prieto, J.M.; Giner, R.M.; Rios, J.L. A mechanistic approach to the in vivo anti- inflammatory activity of sesquiterpenoid compounds isolated from Inula viscosa. Planta Med., 2001, 67, 726-731.
3. Calou, I.B.F.; Sousa, D.I.M.; Cunha, G.M.D.; Brito, G.A.D.; Silveira, E.R.; Rao, V.S.; Santos, F.A. Topically applied diterpenoids from Egletes viscosa (Asteraceae) attenuate the dermal inflammation in mouse ear induced by tetradecanoylphorbol 13-acetate- and oxazolone. Biol. Pharm. Bull., 2008, 31, 1511-1516.
4. Máñez, S.; Hernández, V.; Giner, R.M.; Rios, J.L.; Recio, M.D. Inhibition of pro-inflammatory enzymes by inuviscolide, a sesquiterpene lactone from Inula viscosa. Fitoterapia, 2007, 78, 329-331.
5. Khan, A.L.; Hussain, J.; Hamayun, M.; Gilani, S.A.; Ahmad, S.; Rehman, G.; Kim, Y.H.; Kang, S.M.; Lee, I.J. Secondary metabolites from Inula britannica L. and their biological activities. Molecules, 2010, 15, 1562-1577.
6. Hernandez, V.; Manez, S.; Recio, M.C.; Giner, R.M.; Rios, J.L. Anti-inflammatory profile of dehydrocostic acid, a novel sesquiterpene acid with a pharmacophoric conjugated diene. Eur. J. Pharm. Sci., 2005, 26, 162-169.
7. Rozenblat, S.; Grossman, S.; Bergman, M.; Gottlieb, H.; Cohen, Y.; Dovrat, S. Induction of G(2)/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines. Biochem. Pharm., 2008, 75, 369-382.
8. Bakshi, S.; Bergman, M.; Dovrat, S.; Grossman, S. Unique natural antioxidants (NAOs) and derived purified components inhibit cell cycle progression by downregulation of ppRb and E2F in human PC3 prostate cancer cells. FEBS Lett., 2004, 573, 31-37.
9. Gilmore, T.D. Introduction to NF-kappa B: players, pathways, perspectives. Oncogene, 2006, 25, 6680-6684.
10. Gayathri, B.; Manjula, N.; Vinaykumar, K.S.; Lakshmi, B.S.; Balakrishnan, A. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNF alpha, IL-1 beta, NO and MAP kinases. Int. Immunopharmacol., 2007, 7, 473-482.
11. Soboslay, P.T.; Hamm, D.M.; Pfafflin, F.; Fendt, J.; Banla, M.; Schulz-Key, H. Cytokine and chemokine responses in patients coinfected with Entamoeba histolytica/dispar, Necator americanus and Mansonella perstans and changes after anti-parasite treatment. Microb. Infect., 2006, 8, 238-247.
12. Konig, B.; Streckert, H.J.; Krusat, T.; Konig, W. Respiratory syncytial virus G-protein modulates cytokine release from human peripheral blood mononuclear cells. J. Leuk. Biol., 1996, 59, 403-406.
13. Jager, L.; Merk, H. Arzneimittel-Allergie; Gustav Fischer Verlag: Jena, 1996.
14. O'Bryan, M.K.; Schlatt, S.; Phillips, D.J.; de Kretser, D.M.; Hedger, M.P. Bacterial lipopolysaccharide-induced inflammation compromises testicular function at multiple levels in vivo. Endocrinology, 2000, 141, 238-246.
15. Bessler, H.; Salman, H.; Bergman, M.; Alcalay, Y.; Djaldetti, M. In vitro effect of lycopene on cytokine production by human peripheral blood mononuclear cells. Immunol. Invest., 2008, 37, 183-190.
16. Yardeni, I.Z.; Beilin, B.; Mayburd, E.; Alcalay, Y.; Bessler, H. Relationship between fentanyl dosage and immune function in the postoperative period. J. Opioid Manage., 2008, 4, 27-33.
17. Song, X.P.; Voronov, E.; Dvorkin, T.; Fima, E.; Cagnano, E.; Benharroch, D.; Shendler, Y.; Bjorkdahl, O.; Segal, S.; Dinarello, C.A.; Apte, R.N. Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J. Immunol., 2003, 171, 6448-6456.
18. Song, X.P.; Krelin, Y.; Dvorkin, T.; Bjorkdahl, O.; Segal, S.; Dinarello, C.A.; Voronov, E.; Apte, R.N. CD11b(+)/Gr-1(+) immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1 beta-secreting cells. J. Immunol., 2005, 175, 8200-8208.
19. Moretta, A.; Accolla, R.S.; Cerottini, J.C. Il-2-mediated T-cell proliferation in humans is blocked by a monoclonal-antibody directed against monomorphic determinants of HLA-DR antigens. J. Exp. Med., 1982, 155, 599-604.
20. Mehrotra, P.T.; Donnelly, R.P.; Wong, S.; Kanegane, H.; Geremew, A.; Mostowski, H.S.; Furuke, K.; Siegel, J.P.; Bloom, E.T. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J. Immunol., 1998, 160, 2637-2644.
21. Suzuki, K.; Setoyama, Y.; Yoshimoto, K.; Tsuzaka, K.; Abe, T.; Takeuchi, T. Effect of interleukin-2 on synthesis of B cell activating factor belonging to the tumor necrosis factor family (BAFF) in human peripheral blood mononuclear cells. Cytokine, 2008, 44, 44-48.
22. Farrar, M.A.; Schreiber, R.D. The molecular cell biology of interferon-gamma and its receptor. Ann. Rev. Immunol., 1993, 11, 571-611.
23. Billiau, A. [Interferon-gamma, the TH1/TH2 paradigm in autoimmunity]. Bull. Mem. Acad. R. Med. Belg., 1998, 153, 231-233.
24. Reinhart, T.A.; Fallert, B.A.; Pfeifer, M.E.; Sanghavi, S.; Capuano, S.; Rajakumar, P.; Murphey-Corb, M.; Day, R.; Fuller, C.L.; Schaefer, T.M. Increased expression of the inflammatory chemokine CXC chemokine ligand 9/monokine induced by interferon-gamma in lymphoid tissues of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome. Blood, 2002, 99, 3119-3128.
25. Hershko, D.D.; Robb, B.W.; Luo, G.J.; Hasselgren, P.O. Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2002, 283, R1140-R1148.
26. Myokai, F.; Takashiba, S.; Lebo, R.; Amar, S. A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: Molecular cloning, sequencing, characterization, and chromosomal assignment. Proc. Natl. Acad. Sci. USA, 1999, 96, 4518-4523.
27. Hiscott, J.; Marois, J.; Garoufalis, J.; Daddario, M.; Roulston, A.; Kwan, I.; Pepin, N.; Lacoste, J.; Nguyen, H.; Bensi, G.; Fenton, M. Characterization of a functional Nf-kappa-B Site in the human interleukin-1-beta promoter - evidence for a positive autoregulatory loop. Mol. Cell Biol., 1993, 13, 6231-6240.
28. McCaffrey, P.G.; Jain, J.; Jamieson, C.; Sen, R.; Rao, A. A T-cell nuclear factor resembling Nf-at binds to an Nf-kappa-B site and to the conserved lymphokine promoter sequence Cytokine-1. J. Biol. Chem., 1992, 267, 1864-1871.
29. Lehtonen, A.; Matikainen, S.; Julkunen, I. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J. Immunol., 1997, 159, 794-803.
30. Silva, C.M.; Lu, H.W.; Weber, M.J.; Thorner, M.O. Differential tyrosine phosphorylation of Jak1, Jak2, and Stat1 by growth- hormone and interferon-gamma in IM-9 cells. J. Biol. Chem., 1994, 269, 27532-27539.
31. Gimeno, R.; Lee, C.K.; Schindler, C.; Levy, D.E. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes. Mol. Cell Biol., 2005, 25, 5456-5465.
32. Abrham, G.; Volpe, M.; Shpungin, S.; Nir, U. TMF/ARA160 downregulates proangiogenic genes and attenuates the progression of PC3 xenografts. Int. J. Cancer, 2009, 125, 43-53.
33. Yokosawa, N.; Yokota, S.; Kubota, T.; Fujii, N. C-terminal region of STAT-1 alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J. Virol., 2002, 76, 12683-12690.
34. Rozenblat, S. Anti-cancer activity of Inula viscosa on melanoma cells. PhD thesis. Ramat-Gan: Bar-Ilan University, 2006.
35. Selvakkumar, C.; Gayathri, B.; Vinaykumar, K.S.; Lakshmi, B.S.; Balakrishnan, A. Potential anti-inflammatory properties of crude alcoholic extract of Ocimum basilicum L. in human peripheral blood mononuclear cells. J. Health Sci., 2007, 53, 500-505.
36. Ryo, A.; Suizu, F.; Yoshida, Y.; Perrem, K.; Liou, Y.C.; Wulf, G.; Rottapel, R.; Yamaoka, S.; Lu, K.P. Regulation of NF-kappa B signaling by Pin1-dependent prolyl isomerization and ubiquitin- mediated proteolysis of p65/RelA. Mol. Cell, 2003, 12, 1413-1426.
37. Tanaka, T.; Grusby, M.J.; Kaisho, T. PDLIM2-mediated termination of transcription factor NF-kappa B activation by intranuclear sequestration and degradation of the p65 subunit. Nat. Immunol., 2007, 8, 584-591.
38. García-Piñeres, A.J.; Castro, V.; Mora, G.; Schmidt, T.J.; Strunck, E.; Pahl, H.L.; Merfort, I. Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J. Biol. Chem., 2001, 276, 39713-39720.
39. Ly G.; Knorre, A.; Schmidt, T.J.; Pahl, H.L.; Merfort, I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappa B by directly targeting p65. J. Biol. Chem., 1998, 273, 33508-33516.
40. Azad, N.; Rojanasakul, Y.; Vallyathan, V. Inflammation and lung cancer: Roles of reactive oxygen/nitrogen species. J. Toxicol. Environ. Health - Part B - Crit. Rev., 2008, 11, 1-15.
41. Clevers, H. At the crossroads of inflammation and cancer. Cell, 2004, 118, 671-674.
42. Balkwill, F.; Charles, K.A.; Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell, 2005, 7, 211-217.
43. Coussens, L.M.; Werb, Z. Inflammatory cells and cancer: Think different! J. Exp. Med., 2001, 193, F23-F26.
44. Voronov, E.; Shouval, D.S.; Krelin, Y.; Cagnano, E.; Benharroch, D.; Iwakura, Y.; Dinarello, C.A.; Apte, R.N. IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl. Acad. Sci. USA, 2003, 100, 2645-2650.
45. Ferrer, F.A.; Miller, L.J.; Andrawis, R.I.; Kurtzman, S.H.; Albertsen, P.C.; Laudone, V.P.; Kreutzer, D.L. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology, 1998, 51, 161-167.